MX2017007510A - Un proceso para la fabricacion de idalopirdina. - Google Patents

Un proceso para la fabricacion de idalopirdina.

Info

Publication number: MX2017007510A
Authority: MX; Mexico
Prior art keywords: idalopirdine; manufacture; preparation; disclosed; pharmaceutically acceptable
Prior art date: 2014-12-12

Application number

MX2017007510A

Other languages

English (en)

Spanish (es)

Inventor

Nielsen Ole

Fog Jacobsen Mikkel

Original Assignee

H Lundbeck As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-12-12

Filing date

2015-12-10

Publication date

2017-08-22

2015-12-10 Application filed by H Lundbeck As filed Critical H Lundbeck As

2015-12-10 Priority claimed from PCT/EP2015/079209 external-priority patent/WO2016091997A1/fr

2017-08-22 Publication of MX2017007510A publication Critical patent/MX2017007510A/es

Links

YBAWYTYNMZWMMJ-UHFFFAOYSA-N 2-(6-fluoro-1h-indol-3-yl)-n-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine Chemical compound FC(F)C(F)(F)COC1=CC=CC(CNCCC=2C3=CC=C(F)C=C3NC=2)=C1 YBAWYTYNMZWMMJ-UHFFFAOYSA-N 0.000 title abstract 2
229950005109 idalopirdine Drugs 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

MX2017007510A 2014-12-12 2015-12-10 Un proceso para la fabricacion de idalopirdina. MX2017007510A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA201400721		2014-12-12
PCT/EP2015/079209 WO2016091997A1 (fr)	2014-12-12	2015-12-10	Procédé de fabrication d'idalopirdine

Publications (1)

Publication Number	Publication Date
MX2017007510A true MX2017007510A (es)	2017-08-22

Family

ID=59011415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX2017007510A MX2017007510A (es)	2014-12-12	2015-12-10	Un proceso para la fabricacion de idalopirdina.

Country Status (13)

Country	Link
EP (1)	EP3230265A1 (fr)
JP (1)	JP2017537128A (fr)
KR (1)	KR20170093821A (fr)
CN (1)	CN107001266A (fr)
AU (1)	AU2015359347A1 (fr)
BR (1)	BR112017012021A2 (fr)
CA (1)	CA2968770A1 (fr)
CL (1)	CL2017001466A1 (fr)
CO (1)	CO2017005357A2 (fr)
IL (1)	IL252471A0 (fr)
MA (1)	MA41148A (fr)
MX (1)	MX2017007510A (fr)
RU (1)	RU2017120216A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2015362394C1 (en)	2014-12-12	2021-01-28	Japan Tobacco Inc.	Dihydropyrimidine-2-one compounds and medicinal uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3042685A (en) *		1962-07-03		Process of making g-fluoro tryptamine
PE20081889A1 (es) *	2007-03-23	2009-03-05	Smithkline Beecham Corp	Indol carboxamidas como inhibidores de ikk2
TW201139370A (en) *	2009-12-23	2011-11-16	Lundbeck & Co As H	Processes for the manufacture of a pharmaceutically active agent

2015
- 2015-12-09 MA MA041148A patent/MA41148A/fr unknown
- 2015-12-10 CA CA2968770A patent/CA2968770A1/fr not_active Abandoned
- 2015-12-10 BR BR112017012021A patent/BR112017012021A2/pt not_active Application Discontinuation
- 2015-12-10 MX MX2017007510A patent/MX2017007510A/es unknown
- 2015-12-10 AU AU2015359347A patent/AU2015359347A1/en not_active Abandoned
- 2015-12-10 JP JP2017531139A patent/JP2017537128A/ja active Pending
- 2015-12-10 KR KR1020177015206A patent/KR20170093821A/ko not_active Withdrawn
- 2015-12-10 EP EP15821029.4A patent/EP3230265A1/fr not_active Withdrawn
- 2015-12-10 CN CN201580065028.6A patent/CN107001266A/zh active Pending
- 2015-12-10 RU RU2017120216A patent/RU2017120216A/ru not_active Application Discontinuation
2017
- 2017-05-23 IL IL252471A patent/IL252471A0/en unknown
- 2017-05-26 CO CONC2017/0005357A patent/CO2017005357A2/es unknown
- 2017-06-08 CL CL2017001466A patent/CL2017001466A1/es unknown

Also Published As

Publication number	Publication date
CO2017005357A2 (es)	2017-09-20
BR112017012021A2 (pt)	2018-03-13
CN107001266A (zh)	2017-08-01
IL252471A0 (en)	2017-07-31
AU2015359347A1 (en)	2017-06-08
CA2968770A1 (fr)	2016-06-16
JP2017537128A (ja)	2017-12-14
EP3230265A1 (fr)	2017-10-18
RU2017120216A (ru)	2019-01-15
MA41148A (fr)	2017-10-17
CL2017001466A1 (es)	2018-01-05
KR20170093821A (ko)	2017-08-16

Publication	Publication Date	Title
IN2014CH00247A (fr)	2015-08-14
TW201613872A (en)	2016-04-16	IRAK4 inhibiting agents
MX2021010418A (es)	2023-01-02	Composiciones que comprenden una caseína y métodos para producir las mismas.
WO2016079751A3 (fr)	2016-07-14	Procédé de préparation de vortioxétine et de polymorphes de cette substance
MX2017003131A (es)	2017-06-14	Metodo para la preparacion de 2-alcoxi ciclohexanol.
IN2013MU00646A (fr)	2015-06-26
HRP20190462T1 (hr)	2019-04-19	Postupak proizvodnje karbonatno vezanog artikla oblikovanog tiještenjem
WO2014125506A3 (fr)	2014-12-24	Procédé de préparation d'ivacaftor et de ses intermédiaires
HUP1500584A2 (en)	2017-06-28	Novel process for the preparation of carboprost tromethamine
PL3218351T3 (pl)	2019-12-31	Sposób wytwarzania, wyodrębniania i oczyszczania farmaceutycznie dopuszczalnych postaci AHU-377
MX2016015464A (es)	2017-03-27	Composicion farmaceutica oral de isotretinoina.
EP3099304A4 (fr)	2018-01-10	Nouveaux agents thérapeutiques pour le traitement du glaucome
EP3237424A4 (fr)	2018-07-04	Procédé de préparation de cénicriviroc et d'analogues apparentés
EP3092217A4 (fr)	2017-05-03	Nouveau procédé de préparation d'indacatérol ou de ses sels pharmaceutiquement acceptables
IN2013MU01111A (fr)	2015-05-01
MX2016015465A (es)	2017-03-27	Composicion farmaceutica oral de isotretinoina.
ZA201606653B (en)	2018-05-30	Solid forms of a pharmaceutically active compound
SG11201704523WA (en)	2017-07-28	A process for the manufacture of idalopirdine
MX2017007510A (es)	2017-08-22	Un proceso para la fabricacion de idalopirdina.
EP3221320A4 (fr)	2018-04-25	Procédé de préparation d'ibrutinib
PL3223799T3 (pl)	2020-06-15	Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer
SG11201703330YA (en)	2017-05-30	Iminosugars useful for the treatment of viral diseases
IN2014CH01391A (fr)	2015-09-25
HUP1400518A2 (hu)	2016-05-30	Eljárás tofacitinib elõállítására
WO2014147464A3 (fr)	2015-02-19	Nouveau procédé de préparation de tolcapone